DGOYX
Price
$42.68
Change
+$0.49 (+1.16%)
Updated
Jan 30 closing price
Net Assets
565M
VFINX
Price
$560.68
Change
+$2.95 (+0.53%)
Updated
Jan 30 closing price
Net Assets
1.35T
Ad is loading...

DGOYX vs VFINX

Header iconDGOYX vs VFINX Comparison
Open Charts DGOYX vs VFINXBanner chart's image
Davis Opportunity Y
Price$42.68
Change+$0.49 (+1.16%)
VolumeN/A
Net Assets565M
Vanguard 500 Index Investor
Price$560.68
Change+$2.95 (+0.53%)
VolumeN/A
Net Assets1.35T
DGOYX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGOYX vs. VFINX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGOYX is a StrongBuy and VFINX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.35T vs. DGOYX (565M). DGOYX pays higher dividends than VFINX: DGOYX (1.50) vs VFINX (1.24). DGOYX was incepted earlier than VFINX: DGOYX (27 years) vs VFINX (48 years). VFINX has a lower initial minimum investment than DGOYX: VFINX (0) vs DGOYX (5000000). VFINX annual gain was more profitable for investors over the last year : 24.72 vs. DGOYX (6.40). VFINX return over 5 years is better than : 87.33 vs. DGOYX (28.97).
DGOYXVFINXDGOYX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years48 years-
Gain YTD6.1962.743226%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets565M1.35T0%
Annual Yield % from dividends1.501.24122%
Returns for 1 year6.4024.7226%
Returns for 3 years2.8933.859%
Returns for 5 years28.9787.3333%
Returns for 10 years39.83199.3120%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRST11.180.58
+5.47%
Primis Financial Corp
DBD43.460.80
+1.88%
Diebold Nixdorf
KDP32.240.38
+1.19%
Keurig Dr Pepper
AVAV171.980.70
+0.41%
AeroVironment
UBX2.14-0.10
-4.46%
Unity Biotechnology